Isorhamnetin alleviates lipopolysaccharide-induced acute lung injury by inhibiting mTOR signaling pathway
2022 · Immunopharmacology and Immunotoxicology · 19 citations
https://doi.org/10.1080/08923973.2022.2052892
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
291
Citations
10
h-index
10
i10-index
Yuli Wei is an academic researcher. The author has contributed to research in topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Corneal surgery and disorders & Lung Cancer Treatments and Mutations. The author has an h-index of 10, co-authored 16 publications.
Click to start Chat